Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

14 September 2014: Articles  USA

Severe Hypercalcemia Complicating Recovery of Acute Kidney Injury due to Rhabdomyolysis

Unusual clinical course, Challenging differential diagnosis, Management of emergency care

Lisa Aimee Hechanova BCEF , Seyed Ali Sadjadi ACFG

DOI: 10.12659/AJCR.891046

Am J Case Rep 2014; 15:393-396

0 Comments

Abstract

BACKGROUND: Rhabdomyolysis is frequently complicated by multiple electrolyte abnormalities, including hyperkalemia, hyperphosphatemia, and hypo/hypercalcemia. Hypercalcemia can be severe and life-threatening.

CASE REPORT: A 23-year-old white male suffered severe trauma to his lower extremities after a motor vehicle accident, leading to severe muscle damage, cardiac arrhythmia, cardiac arrest, and oliguric acute kidney injury (AKI), requiring hemodialysis treatment. As expected, he was hypocalcemic during the oliguric phase but during the diuretic phase he developed severe symptomatic hypercalcemia requiring hemodialysis treatment in spite of volume replacement and administration of pamidronate. Hypercalcemia reached a peak of 17.1 mg/dL, corrected for serum albumin and urine output was as high as 11.9 liters daily. Hypercalcemia lasted for 3 weeks and then it returned back to normal levels. Plasma levels of 25-OH and 1-25(OH)2 vitamin D were low, intact parathyroid hormone level was appropriately suppressed, and 24-hour urine calcium was 1194 mg (normal up to 350 mg/daily). Mobilization of calcium from calcium phosphate deposits in the injured muscles seems to be the main reason for hypercalcemia and hypercalciuria in rhabdomyolysis-induced AKI.

CONCLUSIONS: Hypercalcemia is not uncommon during the recovery phase of ATN. Unattended, it can cause severe morbidity and even mortality. Fluid administration, pamidronate, and calcium-free dialysis are some methods used to correct severe hypercalcemia. Over time, hypercalcemia improves in almost all cases.

Keywords: Acute Kidney Injury - therapy, Accidents, Traffic, Calcium - urine, Follow-Up Studies, Hypercalcemia - metabolism, Positron-Emission Tomography, Renal Dialysis - adverse effects, Rhabdomyolysis - diagnosis, Severity of Illness Index, Urinalysis, young adult

Background

Rhabdomyolysis is a common phenomenon that results from muscle breakdown due to trauma, extreme exertion, or myotoxins, causing the release of intracellular contents including potassium, calcium, and phosphorus [1–3], which results in acute kidney injury (AKI) in 10–65% of cases [4–10]. Early hypocalcemia is often seen due to precipitation of calcium with phosphate released from damaged muscle cells, and occasionally hypercalcemia can be seen during the recovery phase due to mobilization of calcium phosphate deposits [11,12]. Herein we present a case of rhabdomyolysis complicated by AKI and profound hypercalcemia and hypercalciuria.

Case Report

A 23-year-old white male suffered severe trauma to his lower extremities after a motor vehicle accident, leading to rhabdomyolysis and oliguric acute renal injury requiring renal replacement therapy. He was admitted to the intensive care unit of another health care facility where he was found to have severe hyperkalemia leading to 5 episodes of cardiac arrest. He was stabilized and then transferred to the Veterans Hospital for continuation of care. In the VA hospital he had severe damage of lower extremities, including compartment syndrome, which eventually culminated in an above the knee amputation of his left lower extremity. While in the intensive care unit, he was oliguric and uremic, and hemodialysis treatment was continued. About 3 weeks after his initial injury, his renal function began to recover; he entered the polyuric phase of AKI, and came off dialysis. During this phase, his serum calcium

started to rise, reaching a peak of 17.1mg/d, corrected for serum albumin (Figure 1), causing nausea, weakness, drowsiness, and polyuria, with urine output up to 11 liters per day. He was treated with intravenous fluids, calcitonin, and pamidronate but he continued to be hypercalcemic. Therefore, he was treated one time with calcium-free dialysate, which he tolerated well and brought down his serum calcium from 15.1 to 7.3 mg/dL, uncorrected for serum albumin. Overall hypercalcemia lasted for about 3 weeks and gradually decreased to normal levels. During this time, plasma levels of 25-OH and 1–25(OH)2 vitamin D levels were 12 ng/mL (normal >30 ng/mL) and <8 ng/mL (normal >30 ng/mL), respectively. Intact parathyroid hormone level was appropriately suppressed and was less than 2.5 pg/mL. A 24-hour urine collection showed excretion of 1194 mg of calcium (normal up to 350 mg/day). A technetium pyrophosphate scan (Figure 2) showed extensive calcium deposition in his left thigh muscles, where he had severe muscle injury and compartment syndrome.

Discussion

Rhabdomyolysis occurs when there is an insult to muscle cells, such as trauma, extreme exertion, ischemia, infection, metabolic derangements, or exposure to myotoxins [13–19], which triggers a chain of events causing progressive derangements in intracellular calcium homeostasis and eventual cell death. In health, the cytoplasmic calcium concentration is very tightly regulated by various calcium pumps/exchangers (e.g., calcium channels, 2Na+/Ca2+ exchanger, and Ca2+ ATPase pump). Calcium is transported from the cytoplasm into the sarcoplasmic reticulum via the calcium ATPase pump, where it is released on stimulation from neural impulses causing muscle contraction. Calcium is also pumped from the cytoplasm to the extracellular space by the 2Na+/Ca2+ exchanger, which moves sodium down its concentration gradient into the cell while moving calcium out of the cell against its concentration gradient. The net result is that the intracellular cytoplasmic ionized calcium concentration is 10 000 times lower than the extracellular ionized calcium concentration [13,20]. In rhabdomyolysis, the 2 main mechanisms that trigger the cascade of events resulting in the demise of the cell are: 1) a lack of ATP, which causes dysfunction of the Na+/K+ ATPase and Ca2+ ATPase, thus causing accumulation of cytosolic calcium; and 2) loss of integrity of the sarcoplasmic reticulum membrane, which also causes increase in cytoplasmic calcium concentration. The increase in cytosolic calcium concentration activates neutral proteases or phospholipases, which damage cell membranes. The release of intracellular contents to the extracellular space further compounds the problem by damaging nearby cells. The inflammatory response to this insult causes ischemia and progressive muscle damage [13]. As the muscle cells are damaged, the intracellular contents, which include potassium, phosphorus, uric acid, and creatinine kinase, are released [1–3]. Since potassium is a predominantly intracellular cation with 70% of the intracellular potassium in muscle cells [21], rhabdomyolysis can cause significant hyperkalemia, with resultant arrhythmias, as seen in this patient. The release of intracellular phosphorus can cause early hypocalcemia due to formation of calcium phosphate deposits on the injured muscles [15], as seen in our patient. During the recovery phase of AKI, the calcium phosphate deposits mobilize, causing hypercalcemia in up to one-third of patients [11,12]. However, it is uncommon to see hypercalcemia as severe as in this case. A review of the 60 current PubMed indexed case reports on hypercalcemia associated with rhabdomyolysis (with available abstracts and/or full-text articles) reveals that this is the third-highest calcium level associated with rhabdomyolysis in the current literature. The highest level of hypercalcemia associated with rhabdomyolysis was 20 mg/dL [22]. There have only been 5 other cases of hypercalcemia with serum calcium level >15 mg/dL in the past 40 years [23–26]. Of the cases in the past 20 years in which the duration of hypercalcemia was reported, the average was 8.6 days, with a median of 10 days. This demonstrates the importance of recognizing the severity of hypercalcemia, which can be associated with rhabdomyolysis. The long duration of hypercalcemia in our case may have been because he was young, as well as the severity of his injuries.

The mechanism of hypercalcemia seems to be the dissolution of deposited calcium phosphate during the diuretic phase of acute kidney injury. Various studies have evaluated parathyroid hormone and vitamin D response to hypocalcemia during the oliguric and to hypercalcemia during the polyuric phase, and the response seems to be appropriate [23]. The fact that our patient had suppressed level of intact parathyroid hormone and low levels of 25-OH and 1–25(OH)2 vitamin D and hypercalciuria is consistent with this line of thinking.

Conclusions

It is crucial to remember that patients with rhabdomyolysis are not out of danger when serum creatinine and urine output start to improve. One must be aware of and watch for severe hypercalcemia, which may occur during the diuretic phase of rhabdomyolysis-induced acute injury. Close follow-up and meticulous management of fluids and electrolytes is of utmost importance to the eventual recovery of kidney function.

References:

1.. Khan FY, Rhabdomyolysis: a review of the literature: Neth J Med, 2009; 67; 272-83, pmid: 19841484

2.. Lerma EV, Nissenson AR, Rhabdomyolysis: Nephrology Secrets, 2012; 90-95, St. Louis, MO, Elsevier

3.. Holt SG, Moore KP, Pathogenesis and treatment of renal dysfunction in rhabdomyolysis: Intensive Care Med, 2001; 27(5); 803-11, pmid: 11430535

4.. Rodriguez E, Soler MJ, Rap O, Risk factors for acute kidney injury in severe rhabdomyolysis: PLoS One, 2013; 8(12); e82992, pmid: 24367578

5.. Delaney KA, Givens ML, Vohra RB, Use of RIFLE criteria to predict the severity and prognosis of acute kidney injury in emergency department patients with rhabdomyolysis: J Emerg Med, 2012; 42(5); 521-28, pmid: 21549548

6.. Morris JA, Mucha P, Ross SE, Acute posttraumatic renal failure: a multicenter perspective: J Trauma, 1991; 31; 1584-90, pmid: 1749026

7.. Melli G, Ghaudhry V, Cornblath DR, Rhabdomyolysis: An evaluation of 475 hospitalized patients: Medicine (Baltimore), 2005; 84(6); 377-85, pmid: 16267412

8.. De Meijer AR, Fikkers BG, de Keijzer MH, Serum creatine kinase as a predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey: Intensive Care Med, 2003; 29(7); 1121-25, pmid: 12768237

9.. Brown CV, Rhee P, Chan L, Preventing renal failure in patients with rhabdomyolysis: Do bicarbonate and mannitol make a difference?: J Trauma, 2004; 56(6); 1191-96, pmid: 15211124

10.. Bosch X, Poch E, Grau JM, Rhabdomyolysis and Acute Kidney Injury: N Engl J Med, 2009; 361; 62-72, pmid: 19571284

11.. Shrestha SM, Berry JL, Davies M, Biphasic hypercalcemia in severe rhabdomyolysis: serial analysis of PTH and vitamin D metabolites. A case report and literature review: Am J Kidney Dis, 2004; 43(3); e31-35, pmid: 14981639

12.. Graziani G, Calvetta A, Cucchiari D, Life-threatening hypercalcemia in patients with rhabdomyolysis-induced oliguric acute renal failure: J Nephrol, 2011; 24; 128-31, pmid: 20954138

13.. Giannoglou GD, Chatzizisis YS, Misirli G, The syndrome of rhabdomyolysis: Pathophysiology and diagnosis: Eur J Intern Med, 2007; 18(2); 90-100, pmid: 17338959

14.. Zimmerman JL, Shen MC, Rhabdomyolysis: Chest, 2013; 144(3); 1058-65, pmid: 24008958

15.. Vanholder R, Sever MS, Erek E, Rhabdomyolysis: J Am Soc Nehprol, 2000; 11(8); 1553-61

16.. Huerta-Alardin AL, Varon J, Marik PE, Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians: Crit Care, 2005; 9(2); 158-69, pmid: 15774072

17.. Frohlich G, Grawe A, Schmidt N, Difficult course of rhabdomyolysis in influenza A/H1N1: Dtsch Med Wochenschr, 2013; 138(46); 2351-54, pmid: 24193860

18.. Wen Z, Chuanwei L, Chunyu Z, Rhabdomyolysis presenting with severe hypokalemia in hypertensive patients: A case series: BMC Res Notes, 2013; 6; 155, pmid: 23594380

19.. Grifoni E, Fabbri A, Ciuti G, Hypokalemia-induced rhabdomyolysis: Intern Emerg Med, 2014; 9(4); 487-88, pmid: 24352794

20.. Zager RA, Rhabdomyolysis and myohemoglobinuric acute renal failure: Kidney Int, 1996; 49(2); 314-26, pmid: 8821813

21.. Weiner ID, Linas SL, Wingo CS, Disorders of Potassium Metabolism: Comprehensive Clinical Nephrology, 2010; 118-19, St. Louis, Missouri, Elsevier

22.. Uchida K, Kondo J, Imoto K, Dissecting aortic aneurysm associated with myonephropathic metabolic syndrome and hypercalcemia: Nihon Kyobu Geka Gakkai Zasshi, 1991; 39(1); 86-89, pmid: 2026921

23.. Sperling LS, Tumlin JA, Case report: delayed hypercalcemia after rhabdomyolysis-induced acute renal failure: Am J Med Sci, 1996; 311(4); 186-88, pmid: 8602649

24.. Olazo E, Sanchez-De La Nieta MD, Rivera F, Massive hypercalcaemia in rhabdomyolysis associated with acute renal failure: Nefrologia, 2012; 32(5); 690-92, pmid: 23013966

25.. Feinstein EI, Akmal M, Telfer N, Delayed hypercalcemia with acute renal failure associated with nontraumatic rhabdomyolysis: Arch Intern Med, 1981; 141(6); 753-55, pmid: 6972199

26.. Koffler A, Friedler RM, Massry SG, Acute Renal Failure Due to Nontraumatic Rhabdomyolysis: Ann Intern Med, 1976; 85(1); 23-28, pmid: 937919

In Press

Case report  China

Thrombolytic Therapy After Return of Spontaneous Circulation in Patients With STEMI From Medically Underdev...

Am J Case Rep In Press; DOI: 10.12659/AJCR.949976  

Case report  Greece

Multilevel Laminectomy for Lumbar Spinal Stenosis With Low Back Pain in Achondroplasia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950290  

Case report  Italy

Fractional CO₂ Laser (SCAR3 Scanner) for a Hypertrophic Retracting Cleft Lip Scar: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950607  

Case report  Saudi Arabia

Postoperative Corneal Dellen Following PreserFlo MicroShunt: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950985  

Most Viewed Current Articles

07 Dec 2021 : Case report  USA 17,691,734

Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Fac...

DOI :10.12659/AJCR.934347

Am J Case Rep 2021; 22:e934347

06 Dec 2021 : Case report  Brazil 164,491

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

21 Jun 2024 : Case report  China (mainland) 113,090

Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...

DOI :10.12659/AJCR.944371

Am J Case Rep 2024; 25:e944371

0:00

07 Mar 2024 : Case report  USA 59,175

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923